Risk prediction in pulmonary hypertension due to chronic heart failure: incremental prognostic value of pulmonary hemodynamics

Abstract

Background There is no generally accepted comprehensive risk prediction model cooperating risk factors associated with heart failure and pulmonary hemodynamics for patients with pulmonary hypertension due to left heart disease (PH-LHD). We aimed to explore outcome correlates and evaluate incremental prognostic value of pulmonary hemodynamics for risk prediction in PH-LHD. Methods Consecutive patients with chronic heart failure undergoing right heart catheterization were prospectively enrolled. The primary endpoint was all-cause mortality. Individual variable selection was performed by machine learning methods. Cox proportional hazards models were conducted to identify the association between variables and mortality. Incremental value of hemodynamics was evaluated based on the Seattle heart failure model (SHFM) and Meta-Analysis Global Group in Chronic Heart Failure (MAGGIC) scores. Results A total of 276 PH-LHD patients were enrolled, with a median follow-up time of 34.7 months. By L1-penalized regression model and random forest approach, diastolic pressure gradient (DPG) and mixed venous oxygen saturation (SvO2) were the hemodynamic predictors most strongly associated with mortality (coefficient: 0.0255 and -0.0176, respectively), with consistent significance after adjusted for SHFM [DPG: HR 1.067, 95% CI 1.024–1.113, P = 0.022; SvO2: HR 0.969, 95% CI 0.953–0.985, P = 0.002] or MAGGIC (DPG: HR 1.069, 95% CI 1.026–1.114, P = 0.011; SvO2: HR 0.970, 95% CI 0.954–0.986, P = 0.004) scores. The inclusion of DPG and SvO2 improved risk prediction compared with using SHFM [net classification improvement (NRI): 0.468 (0.161–0.752); integrated discriminatory index (IDI): 0.092 (0.035–0.171); likelihood ratio test: P < 0.001] or MAGGIC [NRI: 0.298 (0.106–0.615); IDI: 0.084 (0.033–0.151); likelihood ratio: P < 0.001] scores alone. Conclusion In PH-LHD, pulmonary hemodynamics can provide incremental prognostic value for risk prediction. Clinical trial registration: NCT02164526 at https://clinicaltrials.gov.

Heart Disease Prediction Based on Age Detection Using Logistic Regression over Random Forest

“…Diagnosing the grumbling properly and outfitting compelling treatment to cases will characterize the nature of administration. Unfortunate assessment causes awful outcomes that aren't acknowledged (Quan et al 2022). It's vital to diagnose the complaint at an early stage (Sharma et al 2022).…”

“…Many studies have been conducted that result in restrictions on feature selection for science Direct There's been a lot of research that contains Machine data learning approaches authors like (Krishnamoorthi et al 2022). In this paper, we develop a heart disease prediction system that can assist medical professionals in predicting heart disease status (Huang et al 2022). There's been a lot of research into heart disease prediction that contains data learning approaches (Wan et al 2021).…”

Heart Disease Prediction Based on Age Detection using Novel Logistic Regression over Support Vector Machine

“…In Heart Disease Prediction using Novel Logistic Regression related articles around 88 in IEEE Digital Xplore and 95 of this research is to improve the performance accuracy of heart disease prediction (Quan et al 2022). Many studies have been conducted that result in restrictions of feature selection for science Direct There's been a lot of research that contains Machine data learning approaches authors like (Rani and Tiwari 2020).…”